Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 17 pseudogene 1 (KRT17P1) is a genomic locus annotated as a pseudogene related to the protein-coding keratin 17 gene (KRT17). Unlike the functional KRT17 gene—which encodes a type I intermediate filament protein important for epithelial integrity, cell proliferation, wound healing, and tumorigenesis—the pseudogene KRT17P1 has no confirmed protein product or biological function. It is not referenced as a therapeutic target or biomarker in scientific or clinical literature. All disease association, therapeutic relevance, and mechanistic insights relate exclusively to the KRT17 gene and protein, not its pseudogene KRT17P1[1][2][4][5][7]. In summary, KRT17P1 is not a therapeutic target, does not encode a functional receptor/protein, and all known scientific/clinical information concerns its parent gene KRT17. If you intend to annotate a therapeutic target, use "Keratin 17" (KRT17).
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 17 pseudogene 1 (KRT17P1).